**Core Concept:** Serotonin-norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressants that work by inhibiting the reuptake of serotonin and norepinephrine in the brain, increasing their availability and enhancing their neurotransmitter effects. SNRIs include drugs like venlafaxine, duloxetine, and milnacipran.

**Why the Correct Answer is Right:** Venlafaxine is a selective serotonin-norepinephrine reuptake inhibitor, meaning it specifically inhibits the reuptake of both serotonin and norepinephrine, thereby increasing their availability in the synaptic cleft and contributing to its antidepressant effects.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Citalopram):** Citalopram is a selective serotonin reuptake inhibitor (SSRI), not a serotonin-norepinephrine reuptake inhibitor. It selectively inhibits the reuptake of serotonin, but not norepinephrine.

B. **Option B (Fluoxetine):** Similar to citalopram, fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and not a serotonin-norepinephrine reuptake inhibitor. It selectively inhibits the reuptake of serotonin, not norepinephrine.

C. **Option C (Fluvoxamine):** Fluvoxamine is another selective serotonin reuptake inhibitor (SSRI), not a serotonin-norepinephrine reuptake inhibitor. It selectively inhibits the reuptake of serotonin, not norepinephrine.

D. **Option D (Duloxetine):** Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI), which is different from an SNRI like venlafaxine. While duloxetine inhibits the reuptake of both serotonin and norepinephrine, the correct answer (venlafaxine) specifically inhibits the reuptake of both serotonin and norepinephrine, making it an SNRI (serotonin-norepinephrine reuptake inhibitor).

**Clinical Pearl:** The distinction between SSRIs, SNRIs, and SNNIs (serotonin-norepinephrine-dopamine reuptake inhibitors) is important for understanding the pharmacology and mechanism of action of antidepressant medications, as well as predicting potential side effects and therapeutic efficacy. SNRIs, like venlafaxine, are more effective in treating depression with concurrent anxiety symptoms, whereas SSRIs are more effective in treating depression without significant anxiety symptoms. SNNIs are being investigated for their potential in treating depression, anxiety, and motor disorders like Parkinson's disease.